Korean J Med > Volume 77(5); 2009 > Article
The Korean Journal of Medicine 2009;77(5):565-570.
Recent updates on extranodal NK/T-cell lymphoma
Won Seog Kim
Extranodal NK/T-cell lymphoma (ENKL)의 최신지견
김원석
Abstract
Extranodal NK/T-cell lymphoma (ENKL) is a rare subtype of NHL (Non-Hodgkin lymphoma]. It occurs mostly in the nasal and paranal areas. Most of the cases are presented stage I/II. International prognostic index (IPI) can predict the outcome. However, better prognostic model is available such as NKIPI. Because of high expression of p-glycoprotein, ENKL is refractory to chemotherapy. Early stage disease can be bestly treated with concurrent chemoradiation. For advanced stage disease, new clinical trials are now being conducted.
Key Words: Extranodal NK/T-cell lymphoma


TOOLS
METRICS Graph View
  • 1,257 View
  • 24 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next